Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibition

Cancer Research

Volumn 70, Issue 23, 2010, Pages 10002-10011

  Bodenstine, Thomas M ^a   Vaidya, Kedar S ^a   Ismail, Aimen ^a   Beck, Benjamin H ^a   Cook, Leah M ^a   Diers, Anne R ^a,c   Landar, Aimee ^a,c   Welch, Danny R ^a,b,c,d  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CONNEXIN 43; GAP JUNCTION PROTEIN; LY 303511; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL MEMBRANE; CYTOSOL; ENZYME ACTIVITY; ENZYME INHIBITION; GAP JUNCTION; GENE EXPRESSION; HUMAN; HUMAN CELL; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

ANDROSTADIENES; CELL COMMUNICATION; CELL LINE, TUMOR; CELL MEMBRANE; CHROMONES; CONNEXIN 43; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTOSOL; ENZYME ACTIVATION; ENZYME INHIBITORS; FLUORESCEINS; FLUORESCENT ANTIBODY TECHNIQUE; GAP JUNCTIONS; HUMANS; IMMUNOBLOTTING; ISOQUINOLINES; MORPHOLINES; NEOPLASM METASTASIS; NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PIPERAZINES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SULFONAMIDES;

EID: 78649950616     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-2606     Document Type: Article

References (54)

1. Talmadge JE, Fidler IJ. AACR Centennial Series: The biology of cancer metastasis: Historical Perspective. Cancer Res 2010;70:5649-69.
2. Bodenstine TM, Welch DR. Metastasis suppressors and the tumor microenvironment. Cancer Microenviron 2008;1:1-11.
3. Eccles SA, Welch DR. Metastasis: recent discoveries and novel treatment strategies. Lancet 2007;369:1742-57.
4. Samant RS, Debies MT, Hurst DR, Moore BP, Shevde LA, Welch DR. Suppression of murinemammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1). Cancer Lett 2006;235:260-5.
5. Samant RS, Debies MT, Shevde LA, Verderame MF, Welch DR. Identification and characterization of murine ortholog (Brms1) of breast cancer metastasis suppressor 1 (BRMS1). Int J Cancer 2002;97:15-20.
6. Samant RS, Seraj MJ, Saunders MM, Sakamaki TS, Shevde LA, Harms JF, et al. Analysis of mechanisms underlying BRMS1 suppression of metastasis. Clin Exp Metastasis 2001;18:683-93.
7. Seraj MJ, Samant RS, Verderame MF, Welch DR. Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. Cancer Res 2000;60:2764-9.
8. Shevde LA, Samant RS, Goldberg SF, Sikaneta T, Alessandrini A, Donahue HJ, et al. Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1. Exp Cell Res 2002;273:229-39.
9. Zhang S, Lin QD, Di W. Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1. Int J Gynecol Cancer 2006;16:522-31.
10. Smith PW, Liu Y, Siefert SA, Moskaluk CA, Petroni GR, Jones DR. Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and correlates with improved patient survival in non-small cell lung cancer. Cancer Lett 2009;276:196-203.
11. Silveira AC, Hurst DR, Vaidya KS, Ayer DE, Welch DR. Over-expression of the BRMS1 family member SUDS3 does not suppress metastasis of human cancer cells. Cancer Lett 2009;276:32-7.
12. Hurst DR, Xie Y, Vaidya KS, Moore BP, Accavitti-Loper MA, Samant RS, et al. Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells. J Biol Chem 2008;283:7438-44.
13. Meehan WJ, Samant RS, Hopper JE, Carrozza MJ, Shevde LA, Workman JL, et al. Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription. J Biol Chem 2004;279:1562-9.
14. Saunders MM, Seraj MJ, Li ZY, Zhou Z, Winter CR, Welch DR,et al. Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. Cancer Res 2001;61:1765-7.
15. Mese G, Richard G, White TW. Gap junctions: basic structure and function. J Invest Dermatol 2007;127:2516-24.
16. Nicolson GL, Dulski KM, Trosko JE. Loss of intercellular junction communication correlates with metastatic potential in mammary adenocarcinoma cells. Proc Natl Acad Sci USA 1988;85:473-6.
17. Carystinos GD, Bier A, Batist G. The role of connexin-mediated cell-cell communication in breast cancer metastasis. J Mamm Gland Biol Neopl 2001;6:431-40.
18. Mehta PP, Bertram JS, Loewenstein WR. Growth-inhibition of transformed-cells correlates with their junctional communication with normal-cells. Cell 1986;44:187-96.
19. Mesnil M, Crespin S, Avanzo JL, Zaidan-Dagli ML. Defective gap junctional intercellular communication in the carcinogenic process. Biochim Biophys Acta Biomemb 2005;1719:125-45. (Pubitemid 41785641)
20. Nicolson GL, Gallick GE, Dulski KM, Spohn WH, Lembo TM, Tainsky MA. Lack of correlation between intercellular junctional communication, p21rasEJ expression, and spontaneous metastatic properties of rat mammary cells after transfection with c-H-rasEJ or neo genes. Oncogene 1990;5:747-53.
21. Cesen-Cummings K, Fernstrom MJ, Malkinson AM, Ruch RJ. Frequent reduction of gap junctional intercellular communication and connexin43 expression in human and mouse lung carcinoma cells. Carcinogenesis 1998;19:61-7. (Pubitemid 28376827)
22. Zhu D, Cheng C-F, Pauli BU. Mediation of lung metastasis of murine melanomas by a lung-specific endothelial cell adhesion molecule. Proc Natl Acad Sci USA 1991;88:9568-72. (Pubitemid 21915672)
23. Martin W, Zempel G, Hulser D, Willecke K. Growth inhibition of oncogene-transformed rat fibroblasts by cocultured normal cells: relevance of metabolic cooperation mediated by gap junctions. Cancer Res 1991;51:5348-54.
24. Li Z, Zhou Z, Welch DR, Donahue HJ. Expressing connexin 43 in breast cancer cells reduces their metastasis to lungs. Clin Exp Metastasis 2008;25:893-901.
25. Yano T, Fujimoto E, Hagiwara H, Sato H, Yamasaki H, Negishi E, et al. Connexin 32 as an anti-invasive and anti-metastatic gene in renal cell carcinoma. Biol Pharm Bull 2006;29:1991-4.
26. Naus CC, Laird DW. Implications and challenges of connexin connections to cancer. Nat Rev Cancer 2010;10:435-41.
27. Czyz J. The stage-specific function of gap junctions during tumourigenesis. Cell Mol BioLett 2008;13:92-102. (Pubitemid 351679947)
28. Cronier L, Crespin S, Strale PO, Defamie N, Mesnil M. Gap junctions and cancer: new functions for an old story. Antioxid Redox Signal 2009;11:323-38.
29. Sirnes S, Kjenseth A, Leithe E, Rivedal E. Interplay between PKC and the MAP kinase pathway in Connexin43 phosphorylation and inhibition of gap junction intercellular communication. Biochem Biophys Res Commun 2009;382:41-5.
30. Klotz LO, Patak P, Ale-Agha N, Buchczyk DP, Abdelmohsen K, Gerber PA, et al. 2-Methyl-1,4-naphthoquinone, vitamin K-3, decreases gap-junctional intercellular communication via activation of the epidermal growth factor receptor/extracellular signal-regulated kinase cascade. Cancer Res 2002;62:4922-8.
31. DeWald DB, Torabinejad J, Samant RS, Johnston D, Erin N, Shope JC, et al. Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells. Cancer Res 2005;65:713-7.
32. Schubert AL, Schubert W, Spray DC, Lisanti MP. Connexin family members target to lipid raft domains and interact with caveolin-1. Biochemistry 2002;41:5754-64.
33. van Zeijl L, Ponsioen B, Giepmans BNG, Ariaens A, Postma FR, Várnai P, et al. Regulation of connexin43 gap junctional communication by phosphatidylinositol 4,5-bisphosphate. J Cell Biol 2007;177:881-91.
34. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000;24:227-35.
35. Zhang Q, Fan H, Shen J, Hoffman RM, Xing HR. Human breast cancer cell lines co-express neuronal, epithelial, and melanocytic differentiation markers in vitro and in vivo. PLoS One 2010;5:e9712.
36. Chambers AF. MDA-MB-435 and M14 cell lines: identical but not M14 melanoma? Cancer Res 2009;69:5292-3.
37. Montel V, Suzuki M, Galloy C, Mose ES, Tarin D. Expression of melanocyte-related genes in human breast cancer and its implications. Differentiation 2009;78:283-91.
38. DeRosier LC, Buchsbaum DJ, Oliver PG, Huang ZQ, Sellers JC, Grizzle WE, et al. Combination Treatment with TRA-8 Anti-death receptor 5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancer. Clin Cancer Res 2007;13:5535s-43s.
39. Crow DS, Kurata WE, Lau AF. Phosphorylation of connexin 43 in cells containing mutant Src oncogenes. Oncogene 1992;7:999-1003.
40. Bani-Yaghoub M, Bechberger JF, Naus CCG. Reduction of Connexin43 expression and dye-coupling during neuronal differentiation of human NTera2/clone D1 cells. J Neurosci Res 1997;49:19-31.
41. Sato K, Gratas C, Lampe J, Biernat W, Kleihues P, Yamasaki H, et al. Reduced expression of the P2 form of the gap junction protein connexin43 in malignant meningiomas. J Neuropathol Exp Neurol 1997;56:835-9. (Pubitemid 27280194)
42. Husoy T, Knutsen HK, Cruciani W, Olstorn HB, Mikalsen SO, Loberg EM, et al. Connexin 43 is overexpressed in Apc(Min/+)-mice adenomas and colocalises with COX-2 in myofibroblasts. Int J Cancer 2005;116:351-8.
43. Godwin AJ, Green LM, Walsh MP, McDonald JR, Walsh DA, Fletcher WH, et al. In-situ regulation of cell-cell communication by the camp-dependent protein-kinase and protein-kinase-C. Mol Cell Biochem 1993;128:293-307.
44. TenBroek EM, Lampe PD, Solan JL, Reynhout JK, Johnson RG. Ser364 of connexin43 and the upregulation of gap junction assembly by cAMP. J Cell Biol 2001;155:1307-18.
45. Atkinson MM, Lampe PD, Lin HH, Kollander R, Li XR, Kiang DT, et al. cAMP modifies the cellular-distribution of connexin 43 and induces A persistent increase in the junctional permeability of mouse mammary tumor cells. J Cell Sci 1995;108:3079-90.
46. Burghardt RC, Barhoumi R, Sewall TC, Bowen JA. Cyclic AMP induces rapid increases in gap junction permeability and changes in the cellular distribution of Connexin 43. J Membr Biol 1995;148:243-53. (Pubitemid 26017800)
47. Paulson AF, Lampe PD, Meyer RA, TenBroek E, Atkinson MM, Walseth TF, et al. Cyclic AMP and LDL trigger a rapid enhancement in gap junction assembly through a stimulation of connexin trafficking. J Cell Sci 2000;113:3037-49.
48. Laird DW. The gap junction proteome and its relationship to disease. Trends Cell Biol 2010;20:92-101.
49. Vlahos CJ, Matter WF, Hui KY, Brown RF. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 1994;269:5241-8.
50. Ding JB, Vlahos CJ, Liu RC, Brown RF, Badwey JA. Antagonists of phosphatidylinositol 3-kinase block activation of several novel protein-kinases in neutrophils. J Biol Chem 1995;270:11684-91.
51. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000;351:95-105.
52. Ethier MF, Madison JM. LY294002, but not wortmannin, increases intracellular calcium and inhibits calcium transients in bovine and human airway smooth muscle cells. Cell Calcium 2002;32:31-8.
53. Solan JL, Lampe PD. Connexin 43 phosphorylation: structural changes and biological effects. Biochem J 2009;419:261-72.
54. Lampe PD, Lau AF. The effects of connexin phosphorylation on gap junctional communication. Int J Biochem Cell Biol 2004;36:1171-86.